Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityOther Accumulated ExpensesPayablesReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Marker Therapeutics (MRKR) Liabilities from Discontinued Operations (2022 - 2023)

Marker Therapeutics (MRKR) has disclosed Liabilities from Discontinued Operations for 2 consecutive years, with 260280.0 as the latest value for Q2 2023.

  • Quarterly Liabilities from Discontinued Operations changed N/A to 260280.0 in Q2 2023 from the year-ago period, while the trailing twelve-month figure was 260280.0 through Jun 2023, changed N/A year-over-year, with the annual reading at 7039338.0 for FY2022, N/A changed from the prior year.
  • Liabilities from Discontinued Operations for Q2 2023 was 260280.0 at Marker Therapeutics, down from 7039338.0 in the prior quarter.
  • The five-year high for Liabilities from Discontinued Operations was 7039338.0 in Q4 2022, with the low at 260280.0 in Q2 2023.